Twist Bioscience (TWST) Invested Capital (2017 - 2025)
Twist Bioscience (TWST) has disclosed Invested Capital for 9 consecutive years, with $456.1 million as the latest value for Q4 2025.
- Quarterly Invested Capital changed 0.03% to $456.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $456.1 million through Dec 2025, changed 0.03% year-over-year, with the annual reading at $473.0 million for FY2025, 0.06% changed from the prior year.
- Invested Capital for Q4 2025 was $456.1 million at Twist Bioscience, down from $473.0 million in the prior quarter.
- The five-year high for Invested Capital was $863.4 million in Q1 2022, with the low at $440.1 million in Q1 2025.
- Average Invested Capital over 5 years is $603.5 million, with a median of $601.4 million recorded in 2021.
- The sharpest move saw Invested Capital soared 130.75% in 2021, then dropped 25.31% in 2024.
- Over 5 years, Invested Capital stood at $635.3 million in 2021, then rose by 17.48% to $746.3 million in 2022, then decreased by 20.94% to $590.0 million in 2023, then dropped by 22.73% to $455.9 million in 2024, then grew by 0.03% to $456.1 million in 2025.
- According to Business Quant data, Invested Capital over the past three periods came in at $456.1 million, $473.0 million, and $478.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.